Access! 2021 Is Coming. Here’s What You Need to Know

Tuesday April 20, 2021

Access!, AAM’s annual meeting for the generics and biosimilars industry, brings policymakers, influential speakers and industry leaders together to share knowledge and ideas. This year virtual Access! is May 26-27.

We’re excited to welcome attendees to Access! at a considerable discount. This is a one-of-a-kind chance to gain insight into the ever-changing landscape of generics and biosimilars at a more-affordable rate.

  • Members (AAM or Biosimilars Council): $599
  • Nonmembers: $899
  • Government: $399

In addition to a variety of panels across two days, Access! presents top experts from industry and government and keynote speakers Janet Woodcock, M.D., Acting Commissioner, Food and Drug Administration, and Adam Fein, PhD, CEO, Pembroke’s Drug Channels Institute.

C-suite executives; industry, legal and policy professionals; and business development specialists all attend Access! to hear firsthand from world-renowned speakers and learn where our industry is heading and what our future holds.

Why You Should Attend Access!

There’s still time for vendors and organizations to sign up to be an exhibitor. Find out more.

Thanks to our Access! 2021 sponsors:

Stay Informed

Subscribe for Updates

Receive our monthly Biosimilars Bulletin and other important updates on biosimilars in the U.S.


Get Involved

The Council is involved in a number of events that focus on advancing biosimilars in the United States. Click on one below to learn more:



Registration Opens Soon. October 21–23, 2024 | Rockville, MD

GRx+Biosims™ 2024 is the premier regulatory science and policy event for the U.S. generics and biosimilars industry. Access the most recent information straight from experts at the Food and Drug Administration, grasp the latest policies shaping the industry, and acquire valuable insights to propel your professional development.